Provided by Tiger Fintech (Singapore) Pte. Ltd.

Kodiak Sciences Inc.

4.22
+0.30007.65%
Post-market: 4.20-0.0200-0.47%17:47 EDT
Volume:354.24K
Turnover:1.50M
Market Cap:222.10M
PE:-1.17
High:4.39
Open:4.00
Low:3.85
Close:3.92
Loading ...

Kodiak Sciences Inc expected to post a loss of 88 cents a share - Earnings Preview

Reuters
·
24 Mar

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
24 Mar

KOD Completes Enrollment in Phase III Study for Eye Disease Candidate

Zacks
·
11 Mar

Kodiak Sciences completes enrollment in GLOW2 Phase 3 trial

TIPRANKS
·
11 Mar

Kodiak Sciences Completes Enrollment in Second Registrational Trial of Tarcocimab in Patients With Diabetic Retinopathy

THOMSON REUTERS
·
11 Mar

Kodiak Sciences Completes Enrollment in Second Registrational Trial of Tarcocimab in Patients with Diabetic Retinopathy

PR Newswire
·
11 Mar

Kodiak Sciences granted orphan designation for tabirafusp alfa

TIPRANKS
·
05 Mar

We're Keeping An Eye On Kodiak Sciences' (NASDAQ:KOD) Cash Burn Rate

Simply Wall St.
·
25 Feb

Canaccord Genuity Sticks to Their Buy Rating for Kodal Minerals (KOD)

TIPRANKS
·
12 Feb

Kodiak Sciences to Present at Glaucoma 360 New Horizons Forum 2025

PR Newswire
·
04 Feb

Here’s Why Kodiak Sciences Inc. (KOD) Is Skyrocketing

Insider Monkey
·
14 Jan

KOD Stock Rallies 271% in 6 Months on Eye Disease Program Updates

Zacks
·
06 Jan

Institutional investors have a lot riding on Kodiak Sciences Inc. (NASDAQ:KOD) with 43% ownership

Simply Wall St.
·
28 Dec 2024

What Awaits These 4 Biotech Stocks That More Than Doubled in 2024

Zacks
·
26 Dec 2024

Why Rumble Shares Are Trading Higher By Around 43%; Here Are 20 Stocks Moving Premarket

Benzinga
·
23 Dec 2024

KOD Stock Up as Jefferies Upgrades Rating on Huge Pipeline Potential

Zacks
·
10 Dec 2024

Kodiak Sciences, Nona Biosciences partner on next-gen antibody therapies

TIPRANKS
·
10 Dec 2024

Sector Update: Health Care Stocks Edge Higher Monday Afternoon

MT Newswires Live
·
10 Dec 2024

Top Midday Gainers

MT Newswires Live
·
10 Dec 2024

Eye-Disease Focused Kodiak Sciences Is A Promising 'Turnaround Story For 2025': Analyst Upgrades Stock

Benzinga
·
10 Dec 2024